Acute pancreatitis as a rare initial manifestation of 99mTc sestamibi negative parathyroid adenoma- a case report

Kirthika Arunachalam; Mohanapriya Thyagarajan; Kishor Rasipurathanur Jaghannathan; Vineeth Vishwanath

doi:10.18203/2320-6012.ijrms20251002

Authors

Kirthika Arunachalam Department of General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
Mohanapriya Thyagarajan Department of General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
Kishor Rasipurathanur Jaghannathan Department of General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India
Vineeth Vishwanath Department of General Surgery, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20251002

Keywords:

Acute pancreatitis, Hyperparathyroidism, Parathyroid adenoma

Abstract

Parathyroid adenoma is the most common cause of hyperparathyroidism. Hypercalcemia secondary to a benign parathyroid adenoma is a rare cause of acute pancreatitis. This report describes a 57-year-old woman who presented to us with acute pancreatitis. On further evaluation, she was found to have elevated calcium and parathyroid hormone levels. Imaging revealed a 99mTc sestamibi-negative parathyroid adenoma. Diagnosis was confirmed by washout parathyroid hormone measurement from the fine needle aspiration cytology (FNAC) sample. The patient then underwent left superior parathyroidectomy. Postoperatively, the patient had no further episodes of acute pancreatitis or other manifestations of hypercalcemia. The mainstay of treatment for patients with primary hyperparathyroidism includes appropriate resuscitation and stabilization with anti-hypercalcaemic measures, such as hydration and forced calciuresis, followed by definitive surgery.

Metrics

Metrics Loading ...

References

Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98:1122-9. DOI: https://doi.org/10.1210/jc.2012-4022

Popa CC, Badiu DC, Rusu OC, Grigorean VT, Neagu SI, Strugaru CR. Mortality prognostic factors in acute pancreatitis. J Med Life. 2016;9(4):413-8.

Misgar RA, Mathew V, Pandit K, Chowdhury S. Primary hyperparathyroidism presenting as recurrent acute pancreatitis: A case report and review of literature. Indian J Endocrinol Metab. 2011;15(1):54-6. DOI: https://doi.org/10.4103/2230-8210.77588

Leppäniemi A, Tolonen M, Tarasconi A, Segovia-Lohse H, Gamberini E, Kirkpatrick AW, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27. DOI: https://doi.org/10.1186/s13017-019-0247-0

Chatila AT, Bilal M, Guturu P. Evaluation and management of acute pancreatitis. World J Clin Cases. 2019;7(9):1006-20. DOI: https://doi.org/10.12998/wjcc.v7.i9.1006

Smith FB, Cooke RT. Acute fatal hyperparathyroidism. The Lancet. 1940;236(6117):650-1. DOI: https://doi.org/10.1016/S0140-6736(01)08363-5

Pyrah LN, Hodgkinson A, Anderson CK. Primary hyperparathyroidism. Br J Surg. 1966;53(4):245-316. DOI: https://doi.org/10.1002/bjs.1800530402

Banks PA, Freeman ML; Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 2006;101(10):2379-400. DOI: https://doi.org/10.1111/j.1572-0241.2006.00856.x

Bess MA, Edis AJ, van Heerden JA. Hyperparathyroidism and pancreatitis. Chance or a causal association? JAMA. 1980;243:246-7. DOI: https://doi.org/10.1001/jama.1980.03300290028015

Fraser WD. Hyperparathyroidism. The Lancet. 2009;374(9684):145-58. DOI: https://doi.org/10.1016/S0140-6736(09)60507-9

Van Woerkom RC, Adler DG. Acute Pancreatitis: Review and Clinical Update. Hosp Phys. 2009;45:9-19.

Wieneke JA, Smith A. Parathyroid adenoma. Head Neck Pathol. 2008;2(4):305-8. DOI: https://doi.org/10.1007/s12105-008-0088-8

Rahman HA, Haque JA, Sharmin S. Sestamibi Positive Vs Negative Scan In Primary Hyperparathyroidism; A Clinical Dilemma. Bangl J. 2014;17(2). DOI: https://doi.org/10.3329/bjnm.v17i2.28201

Yip L, Pryma DA, Yim JH, Carty SE, Ogilvie JB. Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism. World J Surg. 2009;33(3):426-33. DOI: https://doi.org/10.1007/s00268-008-9841-0

Owens CL, Rekhtman N, Sokoll L, Ali SZ. Parathyroid hormone assay in fine‐needle aspirate is useful in differentiating inadvertently sampled parathyroid tissue from thyroid lesions. Diagnost Cytopathol. 2008;36(4):227-31. DOI: https://doi.org/10.1002/dc.20783

Doppman JL, Krudy AG, Marx SJ, Saxe A, Schneider P, Norton JA, et al. Aspiration of enlarged parathyroid glands for parathyroid hormone assay. Radiology. 1983;148(1):31-5. DOI: https://doi.org/10.1148/radiology.148.1.6856859

Phitayakorn R, McHenry CR. Hyperparathyroid crisis: use of bisphosphonates as a bridge to parathyroidectomy. J Am Coll Surg. 2008;206(6):1106-15. DOI: https://doi.org/10.1016/j.jamcollsurg.2007.11.010